Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.
BMC Med Ethics. 2020 Feb 19;21(1):17. doi: 10.1186/s12910-020-0457-8.
Precision medicine (PM) is an emerging approach to individualized care. It aims to help physicians better comprehend and predict the needs of their patients while effectively adopting in a timely manner the most suitable treatment by promoting the sharing of health data and the implementation of learning healthcare systems. Alongside its promises, PM also entails the risk of exacerbating healthcare inequalities, in particular between ethnoracial groups. One often-neglected underlying reason why this might happen is the impact of structural racism on PM initiatives. Raising awareness as to how structural racism can influence PM initiatives is paramount to avoid that PM ends up reproducing the pre-existing health inequalities between different ethnoracial groups and contributing to the loss of trust in healthcare by minority groups.
We analyse three nodes of a process flow where structural racism can affect PM's implementation. These are: (i) the collection of biased health data during the initial encounter of minority groups with the healthcare system and researchers, (ii) the integration of biased health data for minority groups in PM initiatives and (iii) the influence of structural racism on the deliverables of PM initiatives for minority groups. We underscore that underappreciation of structural racism by stakeholders involved in the PM ecosystem can be at odds with the ambition of ensuring social and racial justice. Potential specific actions related to the analysed nodes are then formulated to help ensure that PM truly adheres to the goal of leaving no one behind, as endorsed by member states of the United Nations for the 2030 Agenda for Sustainable Development.
Structural racism has been entrenched in our societies for centuries and it would be naïve to believe that its impacts will not spill over in the era of PM. PM initiatives need to pay special attention to the discriminatory and harmful impacts that structural racism could have on minority groups involved in their respective projects. It is only by acknowledging and discussing the existence of implicit racial biases and trust issues in healthcare and research domains that proper interventions to remedy them can be implemented.
精准医学(PM)是一种新兴的个体化医疗方法。它旨在通过促进健康数据共享和实施学习型医疗保健系统,帮助医生更好地理解和预测患者的需求,并及时有效地采用最合适的治疗方法。除了带来好处外,PM 还可能加剧医疗保健方面的不平等,特别是在不同族裔群体之间。一个经常被忽视的潜在原因是结构性种族主义对 PM 计划的影响。提高对结构性种族主义如何影响 PM 计划的认识至关重要,以避免 PM 最终复制不同族裔群体之间现有的健康不平等,并导致少数群体对医疗保健失去信任。
我们分析了结构性种族主义可能影响 PM 实施的三个流程节点。这些是:(i)少数群体与医疗保健系统和研究人员初次接触时收集有偏见的健康数据,(ii)将少数群体的有偏见健康数据纳入 PM 计划,(iii)结构性种族主义对 PM 计划为少数群体提供的成果的影响。我们强调,参与 PM 生态系统的利益相关者对结构性种族主义的认识不足,可能与确保社会和种族正义的目标不一致。然后制定了与分析节点相关的潜在具体行动,以帮助确保 PM 真正遵守联合国会员国为 2030 年可持续发展议程所赞同的“不让任何人掉队”的目标。
结构性种族主义在我们的社会中已经存在了几个世纪,如果认为它的影响不会在 PM 时代蔓延,那将是幼稚的。PM 计划需要特别注意结构性种族主义可能对参与各自项目的少数群体产生的歧视性和有害影响。只有承认并讨论医疗保健和研究领域存在的隐性种族偏见和信任问题,才能实施适当的干预措施来纠正这些问题。